Disparities in Reconstruction Rates after Mastectomy for Ductal Carcinoma in Situ (DCIS): Patterns of Care and Factors Associated with the Use of Breast Reconstruction for DCIS Compared with Invasive Cancer
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Many factors influence whether breast cancer patients undergo reconstruction after mastectomy. This study was undertaken to determine the patterns of care and variables associated with the use of reconstruction for ductal carcinoma in situ (DCIS) and to compare previous results for invasive carcinoma.
Postmastectomy reconstruction rates were collected from the California Office of Statewide Health Planning and Development (OSHPD) for 2003–2007. International Classification of Disease-9 codes were used to identify patients undergoing reconstruction after mastectomy. Variations in reconstruction rates were examined by type of breast cancer (DCIS vs. invasive), calendar year, age, type of insurance, type of hospital, and race/ethnicity. Univariate and multivariate odds ratios (OR) with 95% confidence intervals (CI) were estimated for relative odds of immediate reconstruction versus mastectomy only.
For multivariate analysis, age, race/ethnicity, type of insurance, and type of hospital were significantly associated with the use of reconstruction for DCIS patients. DCIS patients were twice as likely to undergo reconstruction as patients with invasive cancer (odds ratio (OR) = 1.93, 95% confidence interval (CI) = 1.75–2.13). DCIS patients with private insurance were nine times more likely to undergo reconstruction as patients with Medicaid (OR = 8.84, 95% CI = 5.92–13.21). Both Hispanic white and Asian patients were one-fifth as likely to undergo reconstruction compared with non-Hispanic white patients (OR = 0.18, 95% CI = 0.1–0.3; OR = 0.17, 95% CI = 0.09–0.31).
Postmastectomy rates for DCIS were twice those for invasive cancer mostly because stage was not a limiting factor. However, significant factors remain that limit the use of reconstruction in this breast cancer population: age, race/ethnicity, type of hospital, and type of insurance.
- Fisher ER, Dignam J, Tan-Chiu E. pathologic findings of the national surgical adjuvant breast project (NSABP) eight-year update of protocol B-17: intraductal carcinoma. Cancer. 1999;86:429–38. CrossRef
- Ernster VL, Barclay J, Kerlikowske K, Wilkie H, Ballard-Barbash R. Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program. Arch Intern Med. 2000;160:953–8. CrossRef
- Brinton LA, Sherman ME, Carreon JD, Anderson WF. Recent trends in breast cancer among younger women in the United States. J Natl Cancer Inst. 2008;100:1643–8. CrossRef
- Jemal A, Siegel R, Ward E, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277–300. CrossRef
- Tuttle TM, Habermann EB, Grund EH, Morris TJ, Virnig BA. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol. 2007;25:1–7. CrossRef
- Tuttle TM, Jarosek S, Habermann EB, Arrington A, Abraham A, Morris TJ, Virnig BA. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol. 2009;25:1–7.
- Elder EE, Brandberg Y, Bjorklund T, et al. Quality of life and patient satisfaction in breast cancer patients after immediate breast reconstruction: a prospective study. Breast. 2005;14:201–8. CrossRef
- Al-Ghazal SK, Fallowfield L, Blamey RW. Comparison of psychological aspects and patient satisfaction following breast conserving surgery, simple mastectomy and breast reconstruction. Eur J Cancer. 2000;36:1938–43. CrossRef
- Brandberg Y, Malm M, Blomqvist L. A prospective and randomized study “SVEA”, comparing effects of three methods for delayed reconstruction on quality of life, patient-defined problem areas of life, and cosmetic result. Plast Reconstr Surg. 2000;105:66–74. CrossRef
- Rowland JH, Desmond KA, Meyerowitz BE, Nelin TR, Wyatt GE, Ganz PA. Role of breast reconstructive surgery in physical and emotional outcomes among breast cancer survivors. J Natl Cancer Inst. 2000;92:1422–9. CrossRef
- Wilkins EG, Cederna PS, Lowery JC, et al. Prospective analysis of psychosocial outcomes in breast reconstruction: one-year postoperative results from the Michigan breast reconstruction outcome study. Plast Reconstr Surg. 2000;106:1014–25. CrossRef
- Morrow M, Scott SK, Menck HR, Mustoe TA, Winchester DP. Factors influencing the use of breast reconstruction postmastectomy: a national cancer database study. J Am Coll Surg. 2001;192:1–8. CrossRef
- Tseng JF, Kronowitz SJ, Sun CC, et al. The effect of ethnicity on immediate reconstruction rates after mastectomy for breast cancer. Cancer. 2004;101:1514–23. CrossRef
- Reuben BC, Manwaring J, Neumayer LA. Recent trends in immediate breast reconstruction after mastectomy in the United States. Am J Surg. 2009;198:237–43. CrossRef
- Polednak AP. Geographic variation in postmastectomy breast reconstruction rates. Plastic Reconstr Surg. 2000; 106:298–301. CrossRef
- Kruper L, Holt A, Xu XX, Duan L, et al. Disparities in reconstruction rates after mastectomy: patterns of care and factors associated with the use of breast reconstruction in southern California. Ann Surg Oncol. 2011;18:2158–65. CrossRef
- Bijker N, Meijnen P, Peterse JL, et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in situ: ten year results of European organisation for research and treatment of cancer randomized phase III trial 10853—a study by the EORTC breast cancer cooperative group and EORTC radiotherapy group. J Clin Oncol. 2006;24:3381–7. CrossRef
- Fisher B, Dignam J, Wolmark N, et al. Tamoxifen in the treatment of intraductal breast cancer: national surgical adjuvant breast and bowel project B-24 randomised controlled trial. Lancet. 1999;353:1993-2000. CrossRef
- Schwarz GF, Solin LJ, Olivotto IA, Ernster VL, Pressman P. The consensus conference on the treatment of in situ ductal carcinoma of the breast, 22-25 April 1999. Breast. 2000;9:177–86. CrossRef
- Rakovitch E, Franssen E, Kim J, et al. A comparison of risk perception and psychological morbidity in women with ductal carcinoma in situ and early invasive breast cancer. Breast Cancer Res Treat. 2003;77:285–93. CrossRef
- Partridge A, Adloff K, Blood E, et al. Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study. J Natl Cancer Inst. 2008;100:243–51. CrossRef
- Bijker N, Peterse JL, Duchteau L, et al. Risk factors for recurrence and metastasis after breast-conserving treatment for ductal carcinoma in situ: analysis of European organisation for research and treatment of cancer trial 10853. J Clin Oncol. 2001;19:2263–71.
- Solin LJ, Forquet A, Vicini FA, et al. Mammographically detected ductal carcinoma in situ of the breast treated with breast-conserving surgery and definitive irradiation: long-term outcome and prognostic significance of patient age and margin status. Int J Radiat Oncol Biol Phys. 2001;50:991–1002. CrossRef
- Goldstein NS, Vicini FA, Kestin LL, Thomas M. Differences in the pathologic features of ductal carcinoma in situ of the breast based on patient age. Cancer. 2000;88:2553–60. CrossRef
- Winchester DJ, Menck HR, Winchester DP. National treatment trends for ductal carcinoma in situ. Arch Surg. 1997;132:660–5.
- Joslyn SA. Ductal carcinoma in situ: trends in geographic, temporal, and demographic patterns of care and survival. Breast J. 2006;12:20–7. CrossRef
- Baxter NN, Virnig BA, Durham SB, Tuttle TM. Trends in the treatment of ductal carcinoma in situ of the breast. J Natl Cancer Inst. 2004;96:443–8. CrossRef
- Rakovitch E, Pignol JP, Chartier C. et al. The management of ductal carcinoma in situ of the breast: a screened population-based analysis. Breast Cancer Res Treat. 2007;101:335–47. CrossRef
- Katz SJ, Lantx PM, Janz NK, et al. Patterns and correlates of local therapy for women with ductal carcinoma in situ. J Clin Oncol. 2005;23:3001–7. CrossRef
- Atisha D. Alderman AK, Lowery JC, Kuhn LE, Davis J, Wilkins EG. Prospective analysis of long-term outcomes in breast reconstruction. Ann Surg. 2008;247:1019–28. CrossRef
- Disa JJ, McCarthy CM, Mehrara BJ, Pusic AL, Hu QY, Cordeiro PG. postmastectomy reconstruction: an approach to patient selection. Plast Reconstr Surg. 2009;124:43–52. http://www.dol.gov/ebsa/publications/whcra.html.
- Alderman AK, Wei Y, Birkmeyer JD. Use of breast reconstruction after mastectomy following the women’s health and cancer rights act. J Am Med Assoc. 2006;387–8.
- Kotwall C, Brinker C, Covington D, et al. Local and national trends over a decade in the surgical treatment of ductal carcinoma in situ. Am J Surg. 2003;186:723–9. CrossRef
- Polednak AP. How frequent if postmastectomy breast reconstructive surgery? A study linking the two statewide databases. Plast Reconstr Surg. 2001;108:73–7. CrossRef
- Alderman AK, McMahon L, Wilkins EG. The national utilization of immediate and early delayed breast reconstruction and the effect of sociodemographic factors. Plast Reconstr Surg. 2003;111:695–703. CrossRef
- Greenberg CC, Schneider EC, Lipsitz SR, et al. Do variations in provider discussions explain socioeconomic disparities in postmastectomy reconstruction? J Am Coll Surg. 2008;206:605–15. CrossRef
- Alderman AK, Hawley ST, Janz NK, et al. Racial and ethnic disparities in the use of postmastectomy breast reconstruction: results from a population-based study. J Clin Oncol. 2009;27:5325–30. CrossRef
- Morrow M, Mujahid M, Lantz PM, et al. Correlates of breast reconstruction. Cancer. 2005;104:2340–6. CrossRef
- Rosson GD, Singh NK, Ahuja N, Jacobs LK, Chang DC. Multilevel analysis of the impact of community vs. patient factors on access to immediate breast reconstruction following mastectomy in Maryland. Arch Surg. 2008;143:1076–81. CrossRef
- Joslyn SA. Patterns of care for immediate and early delayed breast reconstruction following mastectomy. Plast Reconstr Surg. 2005;115:1289–96. CrossRef
- Christian CK, Niland J, Edge SB, et al. A multi-institutional analysis of socioeconomic determinants of breast reconstruction. Ann Surg. 2006;243:241–9. CrossRef
- Katz SJ, Hawley ST, Abrahamse P, et al. Does it matter where you go for breast surgery? Attending surgeon’s influence on variation in receipt of mastectomy for breast cancer. Med Care. 2010;48:892–9. CrossRef
- Pierce LJ. The use of radiotherapy after mastectomy: a review of the literature. J Clin Oncol. 2005;23:1706–17. CrossRef
- Lee BT, Adesiyun TA, Colakoglu S, et al. Postmastectomy radiation therapy and breast reconstruction: an analysis of complications and patient satisfaction. Ann Plast Surg. 2010;64:679–83.
- Tran NV, Evans GR, Kroll SS, Baldwin BJ, Miller MJ, Reece GP, Robb GL. Postoperative adjuvant irradiation: transverse rectus abdominis muscle flap breast reconstruction. Plast Reconstr Surg. 2000;106:313–7. CrossRef
- Chevray PM. Timing of breast reconstruction: immediate versus delayed. Cancer J. 2008;14:223–9. CrossRef
- Krueger EA, Wilkins EG, Strawderman M, et al. Complications and patient satisfaction following expander/implant breast reconstruction with and without radiotherapy. Int J Radiat Oncol Biol Phys. 2001;49:713–21. CrossRef
- Barry M, Kell MR. Radiotherapy and breast reconstruction: a meta-analysis. Breast Cancer Res Treat. 2011;127:15–22. CrossRef
- Metz JM, Solin LJ. Long-term outcome after postmastectomy radiation therapy for the treatment of ductal carcinoma in situ of the breast. Am J Clin Oncol. 1999;22:215–7. CrossRef
- Salas AP, Helvie MA, Wilkins EG, Oberman HA, Possert PW, Yahanda AM, Chang AE. Is mammography useful in screening for local recurrences in patients with TRAM flap breast reconstruction after mastectomy for multifocal DCIS? Ann Surg Oncol. 1998;5:456–63. CrossRef
- Carlson GW, Page A, Johnson E, Nicholson K, Styblo TM, Wood WC. Local recurrence of ductal carcinoma in situ after skin-sparing mastectomy. Am J Coll Surg. 2007;204:1074–80. CrossRef
- Rashtian A, Iganej S, Liu IA, Natarajan S. Close or positive margins after mastectomy for DCIS: pattern of relapse and potential indications for radiotherapy. Int J Radiat Oncol Biol Phys. 2008;72:1016–20. CrossRef
- Chan LW, Rabban J, Hwang ES. Is radiation indicated in patients with ductal carcinoma in situ and close or positive mastectomy margins? Int J Radiat Oncol Biol Phys. 2011;80:25–30. CrossRef
- Chen JY, Malin J, Ganz PA, et al. Variation in physician-patient discussion of breast reconstruction. J Gen Intern Med. 2008;24:99–104. CrossRef
- Bian J, Krontiras H, Allison J. Outpatient mastectomy and breast reconstructive surgery. Ann Surg Oncol. 2007;15:1032–9. CrossRef
- Foster RD, Esserman LJ, Anthony JP, Hwang ES, Do H. Skin-sparing mastectomy and immediate breast reconstruction: a prospective cohort for the treatment of advanced stages of breast carcinoma. Ann Surg Oncol. 2002;9:462–6. CrossRef
- Newman LA, Kuerer HM, Hunt KK, et al. Feasibility of immediate breast reconstruction for locally advanced breast cancer. Ann Surg Oncol. 1999;6:671–5. CrossRef
- Downes KJ, Glatt BS, Kanchwala SK, et al. Skin-sparing mastectomy and immediate reconstruction is an acceptable treatment option for patients with high-risk breast carcinoma. Cancer. 2005;103:906–13. CrossRef
- Styblo TM, Lewis MM, Carlson GW, et al. Immediate breast reconstruction for stage III breast cancer using transverse rectus abdominis musculocutaneous (TRAM) flap. Ann Surg Oncol. 1995;3:375–80. CrossRef
- Disparities in Reconstruction Rates after Mastectomy for Ductal Carcinoma in Situ (DCIS): Patterns of Care and Factors Associated with the Use of Breast Reconstruction for DCIS Compared with Invasive Cancer
Annals of Surgical Oncology
Volume 18, Issue 11 , pp 3210-3219
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Industry Sectors